Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
The Clinical Benefits of HDx Therapy for Chronic HD Patients
The Nephrology Dialysis Transplantation (NDT) Journal has published results of two clinical studies comparing with Theranova dialyzer with the latest generation of high-flux dialyzers.Read More
A Focus on Clinical Research
A mid-term report of HD treatments with the new dialyzers with medium cut-off membrane (MCO Theranova) - Cantaluppi V, et al.
Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up - Schepers E, et al.
Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules - Belmouaz M, et al.
Comparison of high-flux hemodialyzers with medium cut-off dialyzer on the removal of middle high size uremic toxins - Bove S, et al.
Effects on clinical and dialytic parameters with a new medium cut off membrane dialyzer in conventional hemodialysis compared to a high flux dialyzer in online hemodiafiltration - Arrascue FH, et al.
Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration - García-Prieto A, et al.
Expanded hemodialysis vs online hemodiafiltration for middle sized molecules clearance - Santivañez JR, et al.
Expanded hemodialysis: translating innovation to clinical outcomes. NDT Supplement. - Ed: Cozzolino, Blankestijn
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules - Wolley M, et al.